Newron Pharmaceuticals SpA (XSWX:NWRN) 3-Year EBITDA Growth Rate : 15.60% (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Newron Pharmaceuticals SpA 3-Year EBITDA Growth Rate?

Newron Pharmaceuticals SpA's EBITDA per Share for the six months ended in Dec. 2023 was CHF-0.37.

During the past 3 years, the average EBITDA Per Share Growth Rate was 15.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 10.40% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 4.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Newron Pharmaceuticals SpA was 59.60% per year. The lowest was -71.50% per year. And the median was 12.25% per year.

Competitive Comparison of Newron Pharmaceuticals SpA's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Newron Pharmaceuticals SpA's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Newron Pharmaceuticals SpA's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Newron Pharmaceuticals SpA's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Newron Pharmaceuticals SpA's 3-Year EBITDA Growth Rate falls into.

Newron Pharmaceuticals SpA 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Newron Pharmaceuticals SpA (XSWX:NWRN) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Newron Pharmaceuticals SpA 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Newron Pharmaceuticals SpA's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Newron Pharmaceuticals SpA (XSWX:NWRN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (XSWX:NWRN) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

NWPHF:USA NP5:Germany

Address

Via Antonio Meucci 3, Bresso, Milan, ITA, 20091

Website

https://www.newron.com

Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.

Executives

Patrick Langlois

Supervisory Board

Newron Pharmaceuticals SpA (XSWX:NWRN) Headlines

No Headlines